Steve E Wheeler - Insider Trading Tracker

Anika Therapeutics, Inc.

US ˙ NasdaqGS ˙ US0352551081

Introduction

This page provides a comprehensive analysis of the known insider trading history of Steve E Wheeler. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders

Companies with Reported Insider Positions

The SEC filings indicate Steve E Wheeler has reported holdings or trades in the following companies:

Security	Title	Latest Reported Holdings
US:HF / Tidal Trust II - DGA Core Plus Absolute Return ETF	Director	0
US:ANIK / Anika Therapeutics, Inc.	Director	34,594

How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Steve E Wheeler. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ANIK / Anika Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ANIK / Anika Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ANIK / Anika Therapeutics, Inc. Insider Trades

Insider Sales ANIK / Anika Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ANIK / Anika Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2013-08-08	ANIK	WHEELER STEVE E	26,984	23.6100	26,984	23.6100	637,092	8	22.1600	-39,127	-6.14
2013-08-07	ANIK	WHEELER STEVE E	1,098	24.9900	1,098	24.9900	27,439
2013-08-06	ANIK	WHEELER STEVE E	9,918	27.2300	9,918	27.2300	270,067

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Purchases DARP / Tidal Trust II - Grizzle Growth ETF - Short Term Profit Analysis

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DARP / Tidal Trust II - Grizzle Growth ETF Insider Trades

Insider Sales DARP / Tidal Trust II - Grizzle Growth ETF - Short Term Loss Analysis

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Trading History

This table shows the complete list of insider trades made by Steve E Wheeler as disclosed to the Securities Exchange Commission (SEC).

File Date	Tran Date	Form	Ticker	Security	Code	Shares	Remaining Shares	Percent Change	Share Price	Tran Value	Remaining Value
2019-07-01	2019-07-01	4	HF	HFF, Inc. Class A common stock	D - Sale to Issuer	-1,939	0	-100.00
2019-07-01	2019-07-01	4	HF	HFF, Inc. Class A common stock	D - Sale to Issuer	-32,802	0	-100.00
2019-06-04	2019-05-31	4	HF	HFF, Inc. Stock Option	M - Exercise	-6,494	0	-100.00
2019-06-04	2019-05-31	4	HF	HFF, Inc. Class A Common Stock	M - Exercise	6,494	34,741	22.99	7.14	46,367	248,051
2019-05-28	2019-05-23	4	HF	HFF, Inc. Class A common stock	A - Award	1,939	28,247	7.37	43.84	85,006	1,238,348
2018-05-29	2018-05-24	4	HF	HFF, Inc. Class A common stock	A - Award	2,410	25,524	10.43	35.27	85,001	900,231
2018-01-26	2018-01-24	4	ANIK	Anika Therapeutics, Inc. Common Stock	A - Award	1,626	34,594	4.93
2018-01-26	2017-02-16	4	ANIK	Anika Therapeutics, Inc. Common Stock	J - Other	-1,158	32,968	-3.39
2018-01-26	2016-12-22	4	ANIK	Anika Therapeutics, Inc. Common Stock	J - Other	-1,955	34,126	-5.42
2017-05-30	2017-05-25	4	HF	HFF, Inc. Class A common stock	A - Award	2,433	22,449	12.16	30.82	74,985	691,878
2017-01-31	2017-01-27	4	ANIK	Anika Therapeutics, Inc. Common Stock	A - Award	1,994	36,081	5.85
2016-11-04	2016-11-02	4	ANIK	Anika Therapeutics, Inc. Stock Appreciation Right	M - Exercise	-1,090	0	-100.00
2016-11-04	2016-11-02	4	ANIK	Anika Therapeutics, Inc. Common Stock	M - Exercise	1,090	34,087	3.30	12.36	13,472	421,315
2016-05-31	2016-05-26	4	HF	HFF, Inc. Class A common stock	A - Award	2,062	19,248	12.00	31.52	64,994	606,697
2016-02-08	2016-02-04	4	ANIK	Anika Therapeutics, Inc. Common Stock	A - Award	2,361	32,997	7.71
2016-01-28	2016-01-26	4	ANIK	Anika Therapeutics, Inc. Stock Appreciation Right	M - Exercise	-1,770	0	-100.00
2016-01-28	2016-01-26	4	ANIK	Anika Therapeutics, Inc. Common Stock	F - Taxes	-486	30,636	-1.56	38.33	-18,628	1,174,278
2016-01-28	2016-01-26	4	ANIK	Anika Therapeutics, Inc. Common Stock	M - Exercise	1,770	31,122	6.03	10.51	18,603	327,092
2015-08-06	2015-08-05	4	ANIK	Anika Therapeutics, Inc. Common Stock	J - Other	-2,303	29,352	-7.28
2015-08-06	2015-08-05	4	HF	HFF, Inc. Class A common stock	J - Other	-618	16,282	-3.66
2015-06-01	2015-05-28	4	HF	HFF, Inc. Class A common stock	A - Award	1,354	16,900	8.71	40.62	54,999	686,478
2015-02-05	2015-02-04	4	ANIK	Anika Therapeutics, Inc. Stock Options (Right to Buy)	M - Exercise	-1,275	0	-100.00
2015-02-05	2015-02-04	4	ANIK	Anika Therapeutics, Inc. Common Stock	A - Award	1,275	31,655	4.20	14.33	18,271	453,616
2015-02-05	2015-02-03	4	ANIK	Anika Therapeutics, Inc. Common Stock	A - Award	1,511	30,380	5.23
2014-06-16	2014-06-12	4	ANIK	Anika Therapeutics, Inc. Common Stock	J - Other	-22,753	28,869	-44.08
2014-06-16	2014-06-12	4	HF	HFF, Inc. Class A Common Stock	J - Other	-1,401	15,002	-8.54
2014-05-27	2014-05-22	4	HF	HFF, Inc. Class A common stock	A - Award	1,809	16,403	12.40	30.40	54,994	498,651
2014-01-29	2014-01-27	4	ANIK	ANIKA THERAPEUTICS INC Common Stock	A - Award	1,873	51,622	3.76
2013-12-12	2013-12-11	4	ANIK	ANIKA THERAPEUTICS INC Stock Option (Right to Buy)	M - Exercise	-1,530	0	-100.00
2013-12-12	2013-12-11	4	ANIK	ANIKA THERAPEUTICS INC Common Stock	A - Award	1,530	49,749	3.17
2013-08-09	2013-08-08	4	ANIK	ANIKA THERAPEUTICS INC Common Stock	S - Sale	-26,984	48,219	-35.88	23.61	-637,092	1,138,451
2013-08-08	2013-08-07	4	ANIK	ANIKA THERAPEUTICS INC Common Stock	S - Sale	-1,098	75,203	-1.44	24.99	-27,439	1,879,323
2013-08-08	2013-08-06	4	ANIK	ANIKA THERAPEUTICS INC Common Stock	S - Sale	-9,918	76,301	-11.50	27.23	-270,067	2,077,676
2013-05-28	2013-05-23	4	HF	HFF, Inc. Class A common stock	A - Award	1,473	13,902	11.85	20.37	30,005	283,184
2013-05-28	2013-05-23	4	HF	HFF, Inc. Class A common stock	A - Award	1,964	12,429	18.77	20.37	40,007	253,179
2013-01-31	2013-01-29	4	ANIK	ANIKA THERAPEUTICS INC Common Stock	A - Award	2,760	86,219	3.31
2012-05-25	2012-05-24	4	HF	HFF, Inc. Class A common stock	A - Award	3,012	9,533	46.19	13.28	39,999	126,598
2012-02-03	2012-02-25	4	ANIK	ANIKA THERAPEUTICS INC Common Stock	A - Award	3,296	83,459	4.11
2005-06-03	2005-06-01	4	ANIK	ANIKA THERAPEUTICS INC Stock Option (Right to Purchase)	M - Exercise	-10,000	0	-100.00
2005-06-03	2005-06-01	4	ANIK	ANIKA THERAPEUTICS INC Common Stock	M - Exercise	10,000	67,470	17.40	3.12	31,250	210,844

Open market or private purchase of non-derivative or derivative security

Open market or private sale of non-derivative or derivative security

Grant, award, or other acquisition of securities from the company (such as an option)

Conversion of derivative

Sale or transfer of securities back to the company

Payment of exercise price or tax liability using portion of securities received from the company

Gift of securities by or to the insider

Equity swaps and similar hedging transactions

Exercise or conversion of derivative security received from the company (such as an option)

A transaction voluntarily reported on Form 4

Other (accompanied by a footnote describing the transaction)